Medical Weight Loss for Shelton, Connecticut Residents

Shelton, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Shelton through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Shelton, Connecticut by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Shelton Residents Choose New Hope Weight Loss

Some patients in Shelton are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Shelton is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

You do not need a clinic on your street in Shelton to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Connecticut by secure telehealth. We care for patients throughout downtown Shelton and the greater Fairfield County area of the Naugatuck Valley. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Shelton, even on warm Connecticut afternoons.

Your zip code inside Connecticut does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Because every Shelton visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. New Hope Weight Loss serves patients throughout Connecticut by secure telehealth from our Costa Mesa, California clinic, bringing physician-supervised GLP-1 programs to your door without an office visit.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Shelton patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Shelton by telehealth.

How Telehealth Works for Shelton

From your first quiz to your last follow-up, the process is built for busy people in Shelton.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Shelton home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Shelton

I live in Shelton. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Shelton, Connecticut patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Shelton?

No in-person visits are needed for Shelton residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Shelton in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Shelton residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Shelton.

What areas of Shelton do you serve?

We serve patients from across Shelton by telehealth, including downtown Shelton and the greater Fairfield County area of the Naugatuck Valley.

How does compounded medication compare on cost for Shelton patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Shelton patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Shelton Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Shelton, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.